Journal of Epidemiology and Global Health

Volume 5, Issue 4, December 2015, Pages 365 - 373

First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi

Authors
Vithal Prasad Myneedua, *, tbmicro@gmail.com, Ritu Singhala, ritugo@hotmail.com, Khalid Umer Khayyamb, dr.khaliduk@yahoo.com, Prem Prakash Sharmac, ppsharma@hotmail.com, Manpreet Bhallaa, mnprtbhalla@yahoo.com, Digamber Beherad, dirlrsi@gmail.com, Rohit Sarine, tbmicro@gmail.com
aNational Reference Laboratory & WHO Center of Excellence (Tuberculosis), Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India
bDepartment of Epidemiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India
cDepartment of Statistics, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India
dDepartment of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
eDepartment of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India
*Corresponding author at: National Reference Laboratory & WHO Center of Excellence (Tuberculosis), Department of Microbiology, National Institute of Tuberculosis & Respiratory Diseases (NITRD), New Delhi 110030, India. Tel.: +91 26854929, +91 26517826, +91 26854922, +91 126517830, +91 26855094.
Corresponding Author
Vithal Prasad Myneedutbmicro@gmail.com
Received 10 February 2015, Revised 4 April 2015, Accepted 6 April 2015, Available Online 2 May 2015.
DOI
10.1016/j.jegh.2015.04.002How to use a DOI?
Keywords
Antibiotic; Primary; Pulmonary; Multi-drug resistance; Extensively drug resistance
Abstract

There is limited information of level of drug resistance to first-line and second line anti-tuberculosis agents in treatment naïve pulmonary tuberculosis (PTB) patients from the Indian region. Therefore, the present prospective study was conducted to determine the antimicrobial susceptibility to first-line and second line anti-TB drug resistance in such patients. Sputum samples from consecutive treatment naïve PTB cases registered in Lala Ram Sarup (LRS) district, under RNTCP containing 12 Directly Observed Treatment Centre’s (DOTS), were enrolled using cluster sampling technology. A total of 453 samples were received from July 2011 to June 2012. All samples were cultured on solid medium followed by drug susceptibility to first and second line anti-tubercular drugs as per RNTCP guidelines. Primary multi-drug resistance (MDR) was found to be 18/453; (4.0%). Extensively drug resistance (XDR) was found in one strain (0.2%), which was found to be resistant to other antibiotics. Data of drug resistant tuberculosis among treatment naïve TB patients are lacking in India. The presence of XDR-TB and high MDR-TB in small population studied, calls for conducting systematic multi-centric surveillance across the country.

Copyright
© 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Journal of Epidemiology and Global Health
Volume-Issue
5 - 4
Pages
365 - 373
Publication Date
2015/05/02
ISSN (Online)
2210-6014
ISSN (Print)
2210-6006
DOI
10.1016/j.jegh.2015.04.002How to use a DOI?
Copyright
© 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Cite this article

TY  - JOUR
AU  - Vithal Prasad Myneedu
AU  - Ritu Singhal
AU  - Khalid Umer Khayyam
AU  - Prem Prakash Sharma
AU  - Manpreet Bhalla
AU  - Digamber Behera
AU  - Rohit Sarin
PY  - 2015
DA  - 2015/05/02
TI  - First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi
JO  - Journal of Epidemiology and Global Health
SP  - 365
EP  - 373
VL  - 5
IS  - 4
SN  - 2210-6014
UR  - https://doi.org/10.1016/j.jegh.2015.04.002
DO  - 10.1016/j.jegh.2015.04.002
ID  - Myneedu2015
ER  -